Zdrowie i gospodarka · 07/01/2014

FDA Announces Draft Guidance for Self-Monitoring Blood Glucose Test Systems for Over-the-Counter Use

The Food and Drug Administration (FDA) has released a draft guidance document outlining the criteria and studies required for self-monitoring blood glucose test systems intended for over-the-counter use by consumers, with the goal of guiding manufacturers in preparing premarket notifications and conducting performance studies.